Drugs / Amitriptylinoxide
Amitriptylinoxide
also known as
Ambivalon · Amitriptilinoxido · Amitriptyline oxide · Amitriptyline-n-oxide · Amitriptylinoxyde · Amitryptyline-n-oxide · Equilibrin · J9.621K
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02237937 | Sep 2011 → Dec 2014 | major depressive disorder | HolsboerMaschmeyer NeuroChemie GmbH | Unknown | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amitriptylinoxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02237937 ↗ |
| Known as | Ambivalon | ChEMBL registry synonym — accepted as the source's own label CHEMBL627 ↗ |
| Known as | Amitriptilinoxido | ChEMBL registry synonym — accepted as the source's own label CHEMBL627 ↗ |
| Known as | Amitriptyline oxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02374567 ↗ |
| Known as | Amitriptyline-n-oxide | ChEMBL registry synonym — accepted as the source's own label CHEMBL627 ↗ |
| Known as | Amitriptylinoxyde | ChEMBL registry synonym — accepted as the source's own label CHEMBL627 ↗ |
| Known as | Amitryptyline-n-oxide | ChEMBL registry synonym — accepted as the source's own label CHEMBL627 ↗ |
| Known as | Equilibrin | ChEMBL registry synonym — accepted as the source's own label CHEMBL627 ↗ |
| Known as | J9.621K | ChEMBL registry synonym — accepted as the source's own label CHEMBL627 ↗ |
| Modality | Small molecule | — CHEMBL627 ↗ |